| 引用本文：徐靖宇, 汤少梁, 焦慧霖, 毛晓艳.药品集中采购政策下慢性病患者药品福利感知与健康相关生命质量的相关性研究[J].中国卫生政策研究,2024,17(12):37-43 |
|
| 药品集中采购政策下慢性病患者药品福利感知与健康相关生命质量的相关性研究 |
| 投稿时间：2024-11-04 修订日期：2024-12-08 PDF全文浏览 HTML全文浏览 |
| 徐靖宇, 汤少梁, 焦慧霖, 毛晓艳 |
| 南京中医药大学卫生经济管理学院 江苏南京 210023 |
| 摘要:目的：研究药品集中采购政策下慢性病患者药品福利感知与健康相关生命质量的相关性。方法：采用多阶段分层随机抽样方法在江苏省、广东省、黑龙江省、甘肃省和宁夏回族自治区5个省份共抽取1 026名慢性病患者进行问卷调查，分析其中924名患者在药品集中采购后药品福利感知与健康相关生命质量的现状；基于线性回归模型探究药品集中采购政策下慢性病患者药品福利感知与健康相关生命质量的相关性，并按照居住地和患慢性病数量进行分组探讨不同人群间的异质性。结果：药品集中采购政策下慢性病患者药品可负担性感知以及药品可及性感知与健康相关生命质量之间均存在显著相关性(P<0.01)。建议：为改善药品集中采购政策效果，进一步增加慢性病患者的药品福利，国家应不断扩大中选药品品种的覆盖范围，加强对中选药品配送与供应链管理，注重提升药品集中采购政策实施的公平性。 |
| 关键词:药品集中采购 药品福利 慢性病患者 健康相关生命质量 |
| 基金项目:国家自然科学基金面上项目(72074125) |
|
| Study on the correlation between chronic diseases patients' perceived drug benefits and their health-related quality of life under the centralized drug procurement policy |
| XU Jing-yu, TANG Shao-liang, JIAO Hui-lin, MAO Xiao-yan |
| School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing Jiangsu 210023, China |
| Abstract:Objective: To study the correlation between perceived drug benefits and health-related quality of life of chronical disease patients under the centralized drug procurement policy. Methods: A multistage stratified random sampling method was used to select 1 026 patients with chronic diseases in five provinces, namely, Jiangsu, Guangdong, Heilongjiang, Gansu, and Ningxia Hui Autonomous Region, and to analyze the current level of perceived drug benefits and health-related quality of life of 924 patients after centralized drug purchasing. Based on the linear regression model, the correlation between perceived drug benefits and health-related quality of life of patients with chronic diseases under the policy of centralized drug procurement was explored, and the heterogeneity among different populations was explored by grouping them according to the place of residence and the number of chronic diseases. Results: There were significant correlations between the perceived affordability and accessibility of medicines and health-related quality of life of patients with chronic diseases under the centralized drug procurement policy (P<0.01) Recommendations: In order to improve the effect of the centralized drug procurement policy and to further increase the welfare of medicines for patients with chronic diseases, the government should continuously expand the coverage of selected drug categories, strengthen the management of distribution and supply chains for selected drugs, and focus on promoting the fairness of policy implementation. |
| Key words:Centralized drug procurement Drug benefit Chronic disease patients Health-related quality of life |
| 摘要点击次数: 20 全文下载次数: 3 |
|
|
|
|
|
